2017
DOI: 10.1371/journal.pone.0180690
|View full text |Cite
|
Sign up to set email alerts
|

IL-13 is a central mediator of chemical-induced airway hyperreactivity in mice

Abstract: BackgroundWhile the importance of the Th2 cytokine IL-13 as a central mediator of airway hyperreactivity (AHR) has been described in allergic protein-induced asthma, this has never been investigated in chemical-induced asthma.ObjectiveWe examined the importance of IL-13 in a mouse model of chemical-induced AHR, using toluene-2,4-diisocyanate (TDI).MethodsIn a first set-up, wild type (WT) and IL-13 knockout (KO) C57Bl/6 mice were dermally treated on days 1 and 8 with 1% TDI or vehicle (acetone/olive oil) on bot… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 42 publications
(60 reference statements)
1
5
0
Order By: Relevance
“…The increased expression of Th2 cytokines IL-4 and IL-5 by airway inflammatory cells observed in our animal model is in agreement with previous experimental and clinical studies, which shows that these cytokines contribute either directly or indirectly to promoting the differentiation, survival, and function of key allergic effector cells (33). The level of IL-13, the presumed central mediator of murine allergic airway inflammation was the same either by OVA sensitization or after rAsp t 36-challenges (34,35). Conversely, IFN-γ being a cytokine that is released due to Th1 responses did not show any significant change after allergen challenge compared to control.…”
Section: Discussionsupporting
confidence: 92%
“…The increased expression of Th2 cytokines IL-4 and IL-5 by airway inflammatory cells observed in our animal model is in agreement with previous experimental and clinical studies, which shows that these cytokines contribute either directly or indirectly to promoting the differentiation, survival, and function of key allergic effector cells (33). The level of IL-13, the presumed central mediator of murine allergic airway inflammation was the same either by OVA sensitization or after rAsp t 36-challenges (34,35). Conversely, IFN-γ being a cytokine that is released due to Th1 responses did not show any significant change after allergen challenge compared to control.…”
Section: Discussionsupporting
confidence: 92%
“…Epithelial alarmin (TSLP)-induced IL-13 pathway was observed to be among the significantly perturbed pathways that was ameliorated by EUK-134 administration. TSLP is mainly produced by epithelial cells in allergic disorders such as asthma and atopic dermatitis [ 7 , 8 , [61] , [62] , [63] ]. Association between TSLP and disease severity has been reported in asthmatics [ 64 ].…”
Section: Discussionmentioning
confidence: 99%
“…Although it has less effect on mucus hyperplasia and airway hyperresponsiveness, IL-13 regulates airway hyperresponsiveness, promotes mucus hyperplasia, and has an important effect on the occurrence and development of allergic asthma [42]. IL-4, which is involved in the regulation of B cells, together with IL-13, induces the conversion of IgG to IgE and also upregulates the expression of vascular cell adhesion factor-1 (VCAM-1) [43]. After the allergic asthma model was induced in T cell immunodeficiency mice (without IL-4 and IL-13) by OVA, AHR and inflammation were significantly attenuated, and serum IgE and IgG1 levels were also greatly reduced [44].…”
Section: Discussionmentioning
confidence: 99%